Lyka Labs has recognized an impairment loss of approximately INR 23 crores on a subsidiary due to accumulated losses. The company's financial results for the fiscal year 2026 have been published, with June 4 set as the record date for shareholders. An Annual General Meeting (AGM) has been scheduled for August 10.

The National Company Law Appellate Tribunal (NCLAT) has reversed its initial decision, granting insolvency proceedings for Lyka Labs against Modi Lifecare. Modi Lifecare is now given a 30-day deadline to pay a sum of INR 63 lakh to avoid initiating insolvency proceedings.

Today, notable stocks experiencing activity include SPARC, Omaxe, Mastek, JSW Energy, Jindal (India), ITC, and Lyka Labs. Additionally, Airfloa Rail and Transformers & Rectifiers are also attracting attention among investors.

India Ratings has confirmed the bank facilities rating for Lyka Labs at INR 332.8 million (down from INR 363.1 million). The outlook on Lyka Labs remains stable, reflecting their sustained financial credibility.

The National Company Law Tribunal (NCLT) has approved the merger of Lyka Exports and Lyka Labs, effective from April 8, 2026. This consolidation boosts their combined capital to ₹59 crore.